The EU Commission waives commitments regarding the merger between two pharmaceutical companies (Takeda / Shire)

On 28 May 2020, the European Commission waived in their entirety the structural remedies that had been submitted by Takeda in 2018 to have its acquisition of Shire greenlit.

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Stamatis Drakakakis, Argyrios Papaefthymiou, Ellie Gavriilidou, The EU Commission waives commitments regarding the merger between two pharmaceutical companies (Takeda / Shire), 28 May 2020, e-Competitions May 2020, Art. N° 100422

Visites 80

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues